Sales and Marketing

Showing 15 posts of 11527 posts found.

FDA offers Alzheimer’s guidance

February 11, 2013 Research and Development, Sales and Marketing Alzheimer's, FDA, Roche, lilly

The FDA has issued guidance to help companies developing new treatments for patients with early-stage Alzheimer’s disease. The US regulator’s …

Teva appoints Arie Belldegrun to Board of directors

February 11, 2013 Manufacturing and Production, Research and Development, Sales and Marketing Arie Belldegrun, Teva

Teva Pharmaceuticals has announced that Dr Arie Belldegrun has been appointed by the directors of Teva to fill a vacancy …

£20m research boost for Scottish biotech

February 11, 2013 Research and Development, Sales and Marketing Bayer, BioCity Scotland, Dundee, EFPIA

BioCity Scotland and the University of Dundee are to play key roles in a newly-launched pan-European drug discovery project. In …

Sanofi won’t follow trend for spin-offs

February 8, 2013 Sales and Marketing Abbott, Pfizer, Sanofi, Viehbacher

Sanofi’s chief executive Chris Viehbacher says the firm plans to maintain its portfolio of business divisions for the foreseeable future, …

‘Challenging’ Europe slows GSK

February 8, 2013 Sales and Marketing GSK, austerity, restructuring

‘Challenging’ economic conditions in Europe are among the factors GlaxoSmithKline is blaming for its sluggish performance, with turnover worldwide down …

Lilly abandons RA drug

February 8, 2013 Research and Development, Sales and Marketing RA, lilly, tabalumab

Lilly is abandoning its late-stage trial into investigational rheumatoid arthritis (RA) drug tabalumab but insists the move has nothing to …

Lexapro US loss hits Lundbeck

February 7, 2013 Sales and Marketing Danish, Lexapro, Lundbeck

The loss of US patent protection on antidepressant Lexapro has put a significant dent in Lundbeck’s financial performance for 2012. …

Market access: please, no more talk of ‘hurdles’ and ‘obstacles’

February 7, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing barr, market access, pm society

For the UK pharmaceutical industry, biotech or devices firms, any discussion around market access tends to be synonymous with ‘hurdles’ …

Weber Shandwick makes several appointments

February 7, 2013 Medical Communications, Sales and Marketing Weber shandwick

PR firm Weber Shandwick has announced a series of new hires to strengthen its leadership across the strategy, creative, media …

‘Sad and shameful day’ for NHS

February 7, 2013 Sales and Marketing Cameron, GMC, Mid Staffs, NHS

The Department of Health has pledged its commitment “to a renewed focus on putting patients at the centre of everything …

Bayer/Janssen seek Xa inhibitor antidote

February 6, 2013 Research and Development, Sales and Marketing Bayer, Janssen, PRT4445, Xarelto

Bayer HealthCare and Janssen Pharmaceuticals have signed a deal with Portola Pharmaceuticals to evaluate the safety of an investigational antidote …

GSK announces AllTrials support

February 6, 2013 Research and Development, Sales and Marketing ABPI, Bad pharma, GSK, Goldacre

GlaxoSmithKline has this morning found itself in the unusual position of being showered with praise by one of its fiercest …

Aesica recruits operations director

February 5, 2013 Manufacturing and Production, Research and Development, Sales and Marketing Aesica, CMO

Contract manufacturing organisation (CMO) Aesica has appointed Jarrett Palmer as Operations director of its formulated products business unit business. Palmer …

Sanofi celebrates EU approvals

February 5, 2013 Sales and Marketing Lyxumia, Sanofi, Zaltrap, diabetes

Sanofi is celebrating after diabetes treatment Lyxumia (lixisenatide) and metastatic colorectal cancer (mCRC) drug Zaltrap received authorisation in Europe. The …

Recipharm appoints Hans Lennernäs to operating Board

February 5, 2013 Manufacturing and Production, Research and Development, Sales and Marketing Recipharm

Recipharm Pharmaceutical Development AB has announced the appointment of Dr Hans Lennernäs to the company’s Board of directors. Lennernäs is …
The Gateway to Local Adoption Series

Latest content